Skip to main content
Sanford Markowitz, MD, Oncology, Cleveland, OH

SanfordDMarkowitzMD

Oncology Cleveland, OH

Professor of Medicine, Case West Res University

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Join Doximity

Already have an account?

  • Office

    11100 Euclid Ave
    Cleveland, OH 44106
    Phone+1 216-844-8500
    Fax+1 216-986-0596

Summary

  • Dr. Sanford Markowitz, MD is an oncologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio and Illinois. He is a Professor of Medicine at Case West Res University.

Education & Training

  • Yale School of Medicine
    Yale School of MedicineClass of 1980

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1987 - 2026
  • IL State Medical License
    IL State Medical License 1982 - 1993
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Former UK Innovator Contributed to CWRU Biotech Startup Rodeo Therapeutics Acquired by Amgen Inc
    Former UK Innovator Contributed to CWRU Biotech Startup Rodeo Therapeutics Acquired by Amgen IncJune 10th, 2021
  • A Device to Detect Barrett’s Oesophagus and Prevent Oesophageal Cancer
    A Device to Detect Barrett’s Oesophagus and Prevent Oesophageal CancerSeptember 22nd, 2020
  • Swallowable Device to Detect Barrett's Esophagus Receives FDA 510(K) Clearance
    Swallowable Device to Detect Barrett's Esophagus Receives FDA 510(K) ClearanceSeptember 5th, 2019
  • Join now to see all

Grant Support

  • A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its ProgressionCASE WESTERN RESERVE UNIVERSITY2025–2029
  • Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablationCASE WESTERN RESERVE UNIVERSITY2022–2027
  • Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and RegenerationUT SOUTHWESTERN MEDICAL CENTER2021–2026
  • Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and RegenerationUT SOUTHWESTERN MEDICAL CENTER2021–2026